Form 4 for ABBV AbbVie
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001179110-22-001830 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-02-25 | ABBV | SALEKI-GERHARDT AZITA | EVP, Ops | F - Tax | $149.54 | -22.1K | 157.9K | -12% | -$3.31M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2022-02-25 | F | D | 22,108 | $149.54 | 157,912 | D | — | — |